Emergent
Emergent Raises $130M Series C at a $1.5B Valuation
Emergent announced $130M in Series C financing on July 15, 2026. AI coding platform Emergent raised a $130 million Series C led by Creaegis and reached unicorn status just over a year after launch.
Round details
The financing includes backing from Creaegis, Khosla Ventures, SoftBank Vision Fund 2. The company reported a $1.5B valuation alongside the transaction.
- Round: Series C
- Capital announced: $130M
- Total funding reported: $230M
- Headquarters: Bengaluru, India
How the company plans to use the capital
Emergent is scaling an end-to-end coding platform that helps non-technical founders and SMBs build, deploy, test, host, and debug software.
Why this matters for GTM teams
The company’s growth points to demand for outcome-oriented software creation tools sold beyond traditional engineering teams.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: TechCrunch funding report.
Company Info
Investors (3)
Share
Related Reports
Armadin Raises $255.5M Series B for Autonomous Security
Armadin raised a $255.5 million Series B co-led by Andreessen Horowitz and Accel to scale its agentic security platform and its research, training, and go-to-market efforts.
Homeward Raises $120M Series D for Cash Offer and Bridge Financing
Homeward raised a $120 million Series D led by Saluda Grade, plus $330 million in asset-backed debt, to expand cash offer and bridge financing for real estate agents.
Varda Raises $251M Series D for Space-Based Pharmaceutical Processing
Varda Space Industries raised a $251 million Series D led by Lux Capital and Natural Capital to scale space-based pharmaceutical processing.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free